About us
Anteo Diagnostics (ASX:ADO) is an Australian public company with headquarters and fully equipped laboratories at the Brisbane Technology Park in Brisbane, QLD. The company's name is derived from Anteo, a latin root for "anticipate, prevent, precede", reflecting our approach to diagnostics opportunities.
Our core competencies are our own products for rapid assay development and enhancement on different platforms, combined with our experience in intellectual property development, market analysis and multi-tiered commercialisation strategies.
Diagnostic data present significant untapped opportunities in the rapidly evolving healthcare markets.
Anteo Diagnostics evolved from Bio-Layer Corporation Ltd (ASX:BLS), an Australian material science company, established in 1999 and listed on the ASX through a reverse acquisition by SSH Medical (ASX:SSH) in October of 2005. The company developed a platform for the rapid design of novel materials for the biotechnology, diagnostics and pharmaceutical industries. Bio-Layer was re-energised in early 2008 through recapitalization, management and board renewal. A strategy was envisioned that more effectively utilises its core competencies and mitigates risk by expanding its commercialisation opportunities. So the transition was made from a materials science company to a one-stop shop for commercialisation of novel diagnostics opportunities.
